Navigation Links
LA BioMed investigator, Dr. Yutaka Niihara, developing novel cellular therapy
Date:7/26/2012

LOS ANGELES (July 26, 2012) Yutaka Niihara, M.D., lead investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), and his team Fawzia Bardag-Gorce, Ph.D. and Joan Oliva Vilana, Ph.D. - are working with Japanese technology company, CellSeed, Inc., to conduct research and examine how novel cellular therapies can help repair damaged organs, including the eyes, skin, teeth, heart, liver, and kidneys. The research is focused on providing innovative solutions for tissue-engineering through the development of novel cell harvest methods and 3-dimensional living tissue replacement products for "cell-sheet therapy" and regenerative medicine. LA BioMed recently completed the first of a two-year research agreement to study CellSeed's proprietary core technology in regenerative medicine.

"At LA BioMed, we are constantly working to uncover new treatments and therapies that can help patients who need them the most," said David I. Meyer, Ph.D., president and CEO of LA BioMed. "We are pleased to be collaborating with CellSeed, and look forward to further exploring the safety and efficacy of this novel cellular therapy and bringing regenerative medicine to patients worldwide."

Cell-sheet therapy is the process of taking small quantities of a patient's own stem or progenitor cells through biopsy and culturing them in a special cell culturing dish. When the cells have grown sufficiently to create a sheet of cells, the living cell-sheet is collected and transplanted back into the patient again. If the transplant is successful, the cells will differentiate to replace the damaged cells and restore the functions that have been lost. This process can be used to regenerate lost or functionally impaired tissues and organs such as eyes, teeth, skin, heart, liver, bladder, and kidneys.

"We are pleased with the progress we have made so far with this potentially revolutionary technology," said Dr. Niihara. "We have already achieved success in Europe to repair corneal tissues that have been damaged by disease, and are working diligently to conduct the studies necessary to meet the requirements that will enable us to bring this technology to America."

To date, this technology has only been tested in Europe and Japan but with rather dramatic results. Patients with blindness due to a lymbal stem cell deficiency have regained their vision, where there had been no previous treatments available to these patients, and there has been a high success rate for patients with end-stage heart failure who have made a full recovery without a heart transplant.

Dr. Niihara and his collaborators have also experienced success in preclinical work including animal studies in their lab. They are hoping to bring this technology to the United States in the very near future, and are working to broaden the range of commercial opportunities for regenerative medicine to include cardiac muscle patches for myocardial infarction, treatment of periodontal disease, cartilage regeneration, and esophageal cancer treatment, among other conditions.

There are several benefits of regenerative medicine. By using a patient's own tissue or cells, there is an on-demand tissue supply and low risk of tissue rejection. There is also no need to wait for a donor, and there are no histology match or foreign tissue rejection risks involved.


'/>"/>
Contact: Diana Soltesz
diana@dsmmedia.com
818-592-6747
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Related medicine news :

1. LA BioMed offers unique educational and research opportunity to local high school seniors
2. Louisiana Tech biomedical engineering professor earns recognition, funding for research
3. LA BioMed investigator Dr. Christina Wang spearheads study on new male contraceptive gel
4. LA BioMed investigators, Drs. Kevin Bruhn and Noah Craft, develop novel treatment for melanoma
5. UMMS researcher Victor Ambros, Ph.D., named co-recipient of 2012 Janssen Award for Biomedical Research
6. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
7. Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells
8. LA BioMeds Dr. Patricia Dickson researching treatments for neurodegenerative disorders
9. LA BioMed receives Grand Challenges Explorations grant
10. Biomedical researchers receive Hartwell Foundation awards
11. LA BioMeds Dr. John Tsuang examines effects of Ibudilast and metamphetamines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: ... and sells medical devices and wearable sleep respiratory products ... cooperation agreement with Hongyuan Supply Chain Management Co., Ltd. ... 20, 2016, to develop Dehaier,s new Internet medical technology ... will leverage Hongyuan Supply Chain,s sales platform to reach ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: